The time interval from surgery to start of chemotherapy significantly impacts prognosis in patients with advanced serous ovarian carcinoma - Analysis of patient data in the prospective OVCAD study
Hofstetter, G × Concin, N Braicu, I Chekerov, R Sehouli, J Cadron, I Van Gorp, T Trillsch, F Mahner, S Ulmer, H Grimm, C Castillo-Tong, D Cacsire Zeillinger, R Zeimet, A G Vergote, Ignace #
Gynecologic oncology vol:131 issue:1 pages:15-20
Cytoreductive surgery and platinum-based systemic therapy constitute the standard treatment of patients with advanced ovarian cancer. The aim of the present study was to evaluate whether the time interval from surgery to start of chemotherapy has an impact on clinical outcome.